Publications on People Who Inject Drugs (PWID)

Pre-Exposure Prophylaxis (PrEP), “the daily use of antiretrovirals in HIV-uninfected people to block the acquisition of HIV infection,” is a new tool for preventing HIV transmission and has sparked considerable discussion and debate in many communities.

This briefing document highlights the impact on the lives of PWID and their family members of the CAHR programme as well as the continued support needed by PWID to fully realise their right to quality health services that are evidence-based and free from stigma and discrimination.

The sixth round of the IBBS survey was conducted among PWIDs within the Kathmandu Valley with coverage of 340 sample size, funded by TI Pooled Fund, under the leadership of NCASC and in close collaboration with key stakeholders.

This is the sixth round of the IBBS study conducted among PWIDs in Eastern Terai Highway Districts. This survey is a part of the National HIV Surveillance Plan (2012) and National HIV and AIDS Strategy (2011-2016).

This brief seeks to help policymakers and program implementers understand and address the HIV needs and human rights of people who inject drugs.

The sixth of the IBBS survey was conducted among PWIDs within the Pokhara Valley with coverage of 345 sample size, funded by Global Fund, under the leadership of NCASC, Save the Children and in close collaboration with key stakeholders.

The sixth round of the IBBS survey in Kathmandu valley among 340 males among People Who Inject Drugs (PWID) was conducted by NCASC with financial support from the TI Pooled Fund.

This document highlights the outcomes of the war on drugs. It makes clear that the war on drugs is, in reality, a war on people who use drugs, and a war on the communities in which they live.

Nepal has been conducting HIV and STI surveillance particularly among key populations, namely: PWID, FSW and their clients, MSM/TG, and male labor migrants for more than a decade mainly to track changes in HIV and STI prevalence along with behavioral components such as condom use. Hepatitis-B and C screening among PWID has been started in the IBBS surveys from 2015.

The size estimation of key population in districts was conducted in 2010. The population size is to be updated in every 2-3 years interval.

Women-identified drug users and those also living with HIV face significant challenges accessing a broad set of healthcare services, including HIV treatment, care, and support, as well as harm reduction services. These challenges stem from structural, social, and cultural prejudice stemming from punitive drug policies around the world.